Mesothelioma Specialists
A specialist who routinely cares for mesothelioma patients is aware of what to look for on blood tests, imaging tests and other diagnostic tools. Mesothelioma specialists may also offer advanced treatments that improve prognoses.
Take into consideration experience, affiliation with a hospital and availability when selecting an expert in mesothelioma. Patients should feel comfortable and supported throughout each visit.
Raja Flores
Dr. Raja Flores, a mesothelioma expert who has a good reputation for his surgical and patient care expertise, is highly regarded for his expertise. He is currently the chief of the thoracic surgery department at Mount Sinai Medical Center in New York City.
Flores developed his expertise in mesothelioma and lung cancer treatments during his residency at Brigham and Women's Hospital, where he trained with renowned mesothelioma surgeon Dr. David Sugarbaker. He is an expert in treating lung cancer, pleural cancer and esophageal cancer.
He helped pioneer the lung-sparing pleurectomy/decortication surgery that has been successfully used as a curative procedure in scores of mesothelioma cases. He was also instrumental in the development of video-assisted thoracic surgery (VATS) lobectomy which is now the gold treatment for patients suffering from lung cancer. This minimally-invasive procedure requires only three small incisions for the removal of cancerous lung sections.
During his mesothelioma treatment career, Flores has published more than 100 peer-reviewed papers and book chapters. He has received numerous professional distinctions, including being named as a New York Top Doctor and America Top Doctor. He has also participated to numerous clinical studies. One of them looked at the effectiveness treatment of mesothelioma using neoadjuvants.
Mesothelioma can be diagnosed by a physical exam, blood tests and imaging. Patients might not be able to show signs until the disease is at an advanced stage. They may experience throat, chest or abdomen discomfort, fatigue, coughing, and difficulty breathing. A physician can remove the excess fluid in order to check for cancer cells and determine if a patient is suffering from epitheliod or mixed mesothelioma.
Asbestos is the most common cause of mesothelioma. Those who are exposed to asbestos during the construction, maintenance, and repair of power stations, ships, or factories are at a greater chance of mesothelioma development.
A multidisciplinary team can offer patients the most effective mesothelioma treatment. In addition to a surgeon patients should consult radiation and medical oncologists who specialize in mesothelioma treatments. They can create a plan to treat the cancer with chemotherapy or radiation. Patients suffering from mesothelioma should inquire from their doctors about the number of mesothelioma cases they have dealt with.
Robert Cameron
Robert Cameron, a renowned mesothelioma expert, graduated from UCLA's medical school about 30 years ago. Prior to pursuing his mesothelioma-specific training, he completed surgical residency at the National Cancer Institute and Cornell University Medical Center. Patients with mesothelioma benefit from his expertise in lung-sparing surgeries and minimally invasive procedures such as thorascopic surgery. Cameron is a mesothelioma researcher and has published more than 35 articles on thoracic and oncology.
Accident Injury Lawyers is also the chief of surgical thoracic surgery at both University of California Los Angeles and West Los Angeles Veterans Affairs Medical Center mesothelioma centers. He is also the director of thoracic surgery at both the University of California Los Angeles and the West Los Angeles Veterans Affairs Medical Center mesothelioma centers.
Dr. Cameron is a leader in mesothelioma treatments and has helped thousands of asbestos victims. He is committed to improving the quality and access of mesothelioma treatment for patients. He also advocates for patients and their families throughout the treatment process.
Cameron is a mesothelioma specialist with experience in treating both pleural and peritoneal mesothelioma. Cameron is experienced in a variety of surgical mesothelioma treatment options, such as cytoreductive surgeries, hyperthermic intraperitoneal chemotherapeutic treatments and pleurectomy/decortication. He is also skilled in pericardial treatment for mesothelioma which involves the surgical removal of tumors from lining of the heart and surrounding tissues.
When searching for a mesothelioma physician it is crucial to find one that has privileges at a cancer facility you can trust. A reputable specialist has the equipment, staff and clinical trials to make sure you get the care you need. It is also important to bring any relevant work history records and scans of your imaging to your appointment. It is also an excellent idea to bring a friend or family member to aid you in remembering details during your appointment.
If you are not looking to undergo surgery or are not able to undergo it, there are other options for mesothelioma treatments such as immunotherapy and radiation. Many mesothelioma specialists are skilled in coordinating these treatments with surgery. The mesothelioma specialists in your cancer center can help in making these decisions after a mesothelioma diagnoses.
Raphael Bueno
Bueno is a specialist in the treatment of thoracic tumors including mesothelioma. He is currently working to improve the way mesothelioma and other lung cancers are treated and treated. Bueno's research is helping doctors better understand mesothelioma at an atomic level. This knowledge will make it easier for mesothelioma to be diagnosed, and could lead to new ways of treatment.
Raphael Bueno, Chief of Thoracic Surgery and vice-chair of Surgery for Cancer Research in Brigham and Women's Hospital is determined to maintain Brigham and Women's Hospital's status as a world leader in mesothelioma research and treatment. Bueno is the director of the hospital’s International Mesothelioma Program. He has a broad array of expertise when it comes to mesothelioma treatment, diagnosis and prevention.
While the leadership of patient care, and teaching were all important aspects of his professional career but his time at BWH has been dominated by research. He has developed tests that aid surgeons in identifying mesothelioma tumors during a biopsy, and he is developing techniques to make the procedure less and less invasive. He is also researching gender differences in mesothelioma, and how tumors develop.
Bueno started working at BWH as a surgical fellow after he graduated from Harvard Medical School. He worked alongside mesothelioma expert Dr. David Sugarbaker, and he gained a lot of knowledge about mesothelioma through his mentor. After his internship he completed a cardiothoracic surgical residency at Massachusetts General Hospital. He then returned to BWH and set up a private surgery practice and a laboratory for mesothelioma.
One of his most notable accomplishments is the creation of iVats. This system allows surgeons to accurately identify mesothelioma cancers and eliminate them when performing an extrapleural lung pneumonectomy. This technique is a significant improvement over the conventional approach, which is often inaccurate and requires more tissue to be removed than is necessary. The new method has improved the outcomes for patients suffering from mesothelioma.
Bueno is involved in many clinical trials that are designed to develop new methods for mesothelioma diagnosis and treatment. He is a Dana-Farber Cancer Institute member and holds appointments at Brigham and Women's Faulkner Hospital and Carney Hospital. He is also an associate of the American College of Chest Physicians.
Paul Sugarbaker
Paul Sugarbaker is a nationally recognized mesothelioma specialist. He is well-known for his work with peritoneal mesothelioma and abdominal cancers. His innovative method of treating this rare cancer and expanding the scope of treatment has helped improve the odds of survival. He invented, refined and then marketed the method of combining cancer surgery and chemotherapy that is heated to treat peritoneal mesothelioma. This method is now known as the Sugarbaker Procedure. He continues to travel around the globe to teach new surgeons this groundbreaking procedure.
A mesothelioma specialist has many years of experience in treating asbestos-related diseases. They are also conversant with the latest mesothelioma treatments and clinical trials. Patients with mesothelioma should be prepared by having medical records available, a list questions and a desire to communicate to their first appointment with a specialist.
There are different types of mesothelioma physicians, and each one will have their own specialization. These include thoracic surgeons, general surgeons, pulmonologists pathologists, and radiation oncologists. Each of these mesothelioma specialists plays a crucial role in the care of patients.
A thoracic surgeon treats tumors and other problems in the chest cavity, including mesothelioma of the pleural cavity. They may perform lung surgery to remove tumors and improve breathing abilities. They can prescribe medications to ease symptoms or increase life duration.
As a mesothelioma specialist a thoracic surgeon can assist patients with the most difficult treatment options. They can also assist patients in finding mesothelioma groups and other sources.
Paul Sugarbaker received his undergraduate degree from Wheaton College in Illinois. He completed his surgical residency in Boston at Peter Bent Brigham Hospital, an affiliated program of Harvard University. He then moved to Atlanta, Georgia where he worked at Emory University for two years before returning to Washington, D.C.
Paul Sugarbaker, a cancer specialist and surgeon of international repute, is a highly respected surgeon. He has been recognized as one of America's Top Doctors, and he is a part of a variety of professional organizations. He is best known for his ferocious pursuit of a cure for mesothelioma peritoneal which led to the HIPEC procedure (heated intraperitoneal chemotherapy), which has been confirmed to prolong the lives of patients with this rare cancer.